Friend or foe-The Pfizer-BioNTech (BNT162b2) vaccination: A case report of reversible acute acalculous cholecystitis.

Bianca Maria WahlenRuben PeraltaHassan Al-ThaniAyman El-Menyar

Published in: Clinical case reports (2022)

We described a rare case of vaccine-induced acalculous cholecystitis (ACC). A 52-year-old female developed ACC after 8 h of receiving a 3rd dose of the Pfizer-BioNTech COVID-19 vaccination. The symptoms subsided completely with conservative treatment for 12 days, and the ultrasound and laboratory findings went back to normal.

Keyphrases

rare case
coronavirus disease
drug induced
sars cov
liver failure
magnetic resonance imaging
high glucose
diabetic rats
sleep quality
computed tomography
depressive symptoms
endothelial cells
physical activity
respiratory syndrome coronavirus
smoking cessation